Vensica Therapeutics Closes $16 Million Investment Round

Funds will support clinical/regulatory development of the Vensica urology treatment platform Published: Nov. 1, 2021 at…

Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design

The MarketWatch News Department was not involved in the creation of this content. Aldeyra Therapeutics, Inc.…